Targeting JAK-STAT in macrophage activation syndrome-no MAS!
- PMID: 40742725
- DOI: 10.1182/blood.2025029681
Targeting JAK-STAT in macrophage activation syndrome-no MAS!
Comment on
-
Ruxolitinib targets JAK-STAT signaling to modulate neutrophil activation in refractory macrophage activation syndrome.Blood. 2025 Jul 31;146(5):612-627. doi: 10.1182/blood.2024024362. Blood. 2025. PMID: 40388634
Publication types
LinkOut - more resources
Full Text Sources